866-997-4948(US-Canada Toll Free)

United States Adalimumab Biosimilar Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 111 Pages

Notes:
Sales, means the sales volume of Adalimumab Biosimilar
Revenue, means the sales value of Adalimumab Biosimilar

This report studies sales (consumption) of Adalimumab Biosimilar in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Adalimumab Biosimilar in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Adalimumab Biosimilar Market Report 2016
1 Adalimumab Biosimilar Overview
1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Adalimumab Biosimilar
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Adalimumab Biosimilar (2011-2021)
1.4.1 United States Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
1.4.2 United States Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)

2 United States Adalimumab Biosimilar Competition by Manufacturers
2.1 United States Adalimumab Biosimilar Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Adalimumab Biosimilar Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Adalimumab Biosimilar Average Price by Manufactures (2015 and 2016)
2.4 Adalimumab Biosimilar Market Competitive Situation and Trends
2.4.1 Adalimumab Biosimilar Market Concentration Rate
2.4.2 Adalimumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Adalimumab Biosimilar Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Adalimumab Biosimilar Sales and Market Share by Type (2011-2016)
3.2 United States Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
3.3 United States Adalimumab Biosimilar Price by Type (2011-2016)
3.4 United States Adalimumab Biosimilar Sales Growth Rate by Type (2011-2016)

4 United States Adalimumab Biosimilar Sales (Volume) by Application (2011-2016)
4.1 United States Adalimumab Biosimilar Sales and Market Share by Application (2011-2016)
4.2 United States Adalimumab Biosimilar Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Adalimumab Biosimilar Manufacturers Profiles/Analysis
5.1 AET BioTech
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Adalimumab Biosimilar Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Amgen
5.2.2 Adalimumab Biosimilar Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim
5.3.2 Adalimumab Biosimilar Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Coherus Biosciences
5.4.2 Adalimumab Biosimilar Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Fujifilm Kyowa Kirin Biologics
5.5.2 Adalimumab Biosimilar Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 LG Life Sciences/Mochida Pharmaceutical
5.6.2 Adalimumab Biosimilar Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Momenta Pharmaceuticals
5.7.2 Adalimumab Biosimilar Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Oncobiologics
5.8.2 Adalimumab Biosimilar Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Pfizer
5.9.2 Adalimumab Biosimilar Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Samsung Bioepsis
5.10.2 Adalimumab Biosimilar Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Sandoz
5.12 Zydus Cadila

6 Adalimumab Biosimilar Manufacturing Cost Analysis
6.1 Adalimumab Biosimilar Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Adalimumab Biosimilar

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Adalimumab Biosimilar Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Adalimumab Biosimilar Market Forecast (2016-2021)
10.1 United States Adalimumab Biosimilar Sales, Revenue Forecast (2016-2021)
10.2 United States Adalimumab Biosimilar Sales Forecast by Type (2016-2021)
10.3 United States Adalimumab Biosimilar Sales Forecast by Application (2016-2021)
10.4 Adalimumab Biosimilar Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Adalimumab Biosimilar
Table Classification of Adalimumab Biosimilar
Figure United States Sales Market Share of Adalimumab Biosimilar by Type in 2015
Table Application of Adalimumab Biosimilar
Figure United States Sales Market Share of Adalimumab Biosimilar by Application in 2015
Figure United States Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
Figure United States Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Table United States Adalimumab Biosimilar Sales of Key Manufacturers (2015 and 2016)
Table United States Adalimumab Biosimilar Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Adalimumab Biosimilar Sales Share by Manufacturers
Figure 2016 Adalimumab Biosimilar Sales Share by Manufacturers
Table United States Adalimumab Biosimilar Revenue by Manufacturers (2015 and 2016)
Table United States Adalimumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Adalimumab Biosimilar Revenue Share by Manufacturers
Table 2016 United States Adalimumab Biosimilar Revenue Share by Manufacturers
Table United States Market Adalimumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Adalimumab Biosimilar Average Price of Key Manufacturers in 2015
Figure Adalimumab Biosimilar Market Share of Top 3 Manufacturers
Figure Adalimumab Biosimilar Market Share of Top 5 Manufacturers
Table United States Adalimumab Biosimilar Sales by Type (2011-2016)
Table United States Adalimumab Biosimilar Sales Share by Type (2011-2016)
Figure United States Adalimumab Biosimilar Sales Market Share by Type in 2015
Table United States Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
Table United States Adalimumab Biosimilar Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adalimumab Biosimilar by Type (2011-2016)
Table United States Adalimumab Biosimilar Price by Type (2011-2016)
Figure United States Adalimumab Biosimilar Sales Growth Rate by Type (2011-2016)
Table United States Adalimumab Biosimilar Sales by Application (2011-2016)
Table United States Adalimumab Biosimilar Sales Market Share by Application (2011-2016)
Figure United States Adalimumab Biosimilar Sales Market Share by Application in 2015
Table United States Adalimumab Biosimilar Sales Growth Rate by Application (2011-2016)
Figure United States Adalimumab Biosimilar Sales Growth Rate by Application (2011-2016)
Table AET BioTech Basic Information List
Table AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AET BioTech Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Coherus Biosciences Basic Information List
Table Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Coherus Biosciences Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Market Share (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information List
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Momenta Pharmaceuticals Basic Information List
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Samsung Bioepsis Basic Information List
Table Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Bioepsis Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure United States Adalimumab Biosimilar Production and Growth Rate Forecast (2016-2021)
Figure United States Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table United States Adalimumab Biosimilar Production Forecast by Type (2016-2021)
Table United States Adalimumab Biosimilar Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *